ECULIZUMAB - HIGH PRICE TREATMENT FOR PRICELESS KIDNEY GRAFT FUNCTION IN A PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME SHORTLY AFTER ALLOGENIC KIDNEY RE-TRANSPLANTATION

Goess R.; Schirren R.; Matevossian E.; Renders L.; Thorban S.; Friess H.

首页> 外文期刊>Transplant international : >ECULIZUMAB - HIGH PRICE TREATMENT FOR PRICELESS KIDNEY GRAFT FUNCTION IN A PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME SHORTLY AFTER ALLOGENIC KIDNEY RE-TRANSPLANTATION

【24h】

ECULIZUMAB - HIGH PRICE TREATMENT FOR PRICELESS KIDNEY GRAFT FUNCTION IN A PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME SHORTLY AFTER ALLOGENIC KIDNEY RE-TRANSPLANTATION

机译：ECULIZUMAB-异基因肾移植后不久发生非典型溶血性尿毒症综合征患者的无价肾移植功能的高价治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplant international : 》 |2016年第3期| 共1页
作者
Goess R.; Schirren R.; Matevossian E.; Renders L.; Thorban S.; Friess H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术 ;
关键词

相似文献

外文文献
中文文献
专利

1. ECULIZUMAB - HIGH PRICE TREATMENT FOR PRICELESS KIDNEY GRAFT FUNCTION IN A PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME SHORTLY AFTER ALLOGENIC KIDNEY RE-TRANSPLANTATION [J] . Goess R., Schirren R., Matevossian E., Transplant international : . 2016 ,第Suppla3期

机译：ECULIZUMAB-异基因肾移植后不久发生非典型溶血性尿毒症综合征患者的无价肾移植功能的高价治疗
2. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases. [J] . Fadi Fakhouri, Yahsou Delmas, Fran?ois Provot, American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2014 ,第1期

机译：从依库丽单抗治疗影响天然肾脏的非典型溶血性尿毒症综合征成年患者的临床实践中获得的见解：分析19例。
3. Pregnancy in a Kidney Transplant Woman Under Treatment With Eculizumab for?Atypical Hemolytic Uremic Syndrome: Is?It Safe? [J] . Anna Duval, Jér?me Olagne, No?lle Cognard, Kidney International Reports . 2019 ,第5期

机译：接受依库丽单抗治疗的非典型溶血性尿毒症综合征患者的肾脏移植妇女是否安全？
4. Fabrication of zeolite-polymer composite nanofibers for removal of uremic toxins from kidney failure patients [C] . Koki Namekawa, Makoto Tokoro Schreiber, Mitsuhiro Ebara, Society for Biomaterials annual meeting and exposition . 2014

机译：用于去除肾衰竭患者尿毒症毒素的沸石-聚合物复合纳米纤维的制备
5. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study [D] . Kitchlu, Abhijat. 2019

机译：癌症患者急性肾损伤患者癌症患者：基于人群的群组研究
6. Prophylactic or Early Use of Eculizumab and Graft Survival in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome in the United States: Research Letter [O] . Richard A. Plasse, Stephen W. Olson, Christina M. Yuan, 2021

机译：肾移植受者的预防性或早期使用肾移植受者的非典型溶血性尿毒症综合征在美国：研究信
7. Greenbaum LA, Fila M, Ardissino G, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89:701–711 [O] . 2016

机译：Greenbaum LA，Fila M，Ardissino G等。依库丽单抗是非典型溶血性尿毒症综合征患儿的一种安全有效的治疗方法。肾脏国际2016; 89：701–711
8. Report of Center-Specific Graft and Patient Survival Rates, 1991. Kidney Data [R] . 1992

机译：中心特异性移植物和患者存活率的报告，1991年。肾脏数据

ECULIZUMAB - HIGH PRICE TREATMENT FOR PRICELESS KIDNEY GRAFT FUNCTION IN A PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME SHORTLY AFTER ALLOGENIC KIDNEY RE-TRANSPLANTATION

著录项

相似文献

相关主题

期刊订阅